I don’t talk much about the value of bisantrene with those new to Race as it just drives away people - you have to have done a lot of research on your own before you understand the potential of what we have. What I tend to concentrate on is the low development risk due to the historical data and the discoveries we have made in drug delivery (reformulation) and best use (cardioprotection). I don’t talk much about FTO/m6A these days as it is too complex and blue sky.
Industry news, page-1612
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
0.008(0.49%) |
Mkt cap ! $267.5M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.57 | $1.54 | $22.94K | 14.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20661 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.54 | 1500 | 1 |
View Market Depth
| Last trade - 12.20pm 17/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |